Trial Design
This was a parallel-group randomized clinical trial with participants randomized 1:1 to receive risk-stratified or usual care. Ethics approval was provided by the institutional review board at Brooke Army Medical Center. The trial was reported using the Consolidated Standards of Reporting Trials (